Find your next paid study

University of North Carolina, Chapel HillNCT07596888

Phase 4

Short-term Effects of Methamphetamine on Residual Latent HIV Disease (EMRLHD) Study

The most commonly used illicit stimulant in people with HIV (PWH) is methamphetamine (MA). Prior studies demonstrate strong evidence that MA promotes increased…

HIV -1 InfectionMethamphetamine Use

University of California, San FranciscoNCT07584369

~$10 – $5,625

Phase 2

Baricitinib Curative Repression of HIV-1

This study is being done to test whether a drug called baricitinib, which blocks specific causes of inflammation, affects HIV-1 viral rebound and viral load le…

HIV InfectionHIV

Emory UniversityNCT07209267

Phase 1

A Phase 1 Study to Assess Safety and Tolerability of Amicidin-β Topical Solution in Adult Patients Undergoing Interventional Management of a Surgical or Traumatic Wound Infection

The goal of this Phase 1 clinical trial is to learn about the safety profile of Amicidin-β topical solution applied directly into infected surgical or traumati…

Surgical Wound InfectionTraumatic Wound Infection

Macro Biologics, Inc.NCT07379684

Observational

Screen2Prevent (S2P): Using Digital Health to Improve HIV Screening and Prevention for Adolescents in the Emergency Department

Screen2Prevent is a study intended to improve HIV prevention and detection through implementation and evaluation of three different broad-scale HIV screening a…

Impact of Prophylactic Use of Irrisept Irrigation System for Spinal Instrumentation

Various spine surgeons perform wound irrigation using saline mixed with vancomycin, relying on mechanical debridement of non-viable tissue, physical disruption…

Post-Op ComplicationSpine SurgerySite Infection+5 more

Rhode Island HospitalNCT06439953

Phase 3

A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Switching to Long-acting Antiretroviral Therapy of Broadly Neutralizing Antibodies Teropavimab and Zinlirvimab in Combination With the Capsid Inhibitor Lenacapavir Twice-Yearly Versus Cabotegravir and Rilpivirine Every 8 Weeks in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

The goal of this clinical study is to compare how effective a long-acting injectable treatment of lenacapavir (LEN), teropavimab (TAB), and zinlirvimab (ZAB) v…

HIV Infections

Gilead SciencesNCT07682961

~$10 – $7,500

Phase 1

Levothyroxine Supplementation for Heart Transplant Recipients: A Randomized Control Trial

This will be a prospective, randomized study performed at a single tertiary referral academic medical center (University of California San Francisco, CA), eval…

Heart Transplant FailureHeart Transplant Infection

University of California, San FranciscoNCT06428097

~$10 – $5,625

Phase 4

A Randomized, Open-Label Study to Assess Pharmacokinetics of Xifaxan® 200 mg in Pediatric Subjects 6 to 11 Years of Age With Acute Diarrhea of Suspected Bacterial Etiology, and the Safety and Efficacy of Xifaxan® 200 mg Plus Oral Rehydration Therapy (ORT) Compared to ORT Alone

The goal of this clinical trial is to learn how rifaximin 200 mg is processed in the body (pharmacokinetics) in children 6 to 11 years old with acute diarrhea …

DiarrheaGastroenteritisBacterial Infection+1 more

Bausch Health Americas, Inc.NCT07285785

Observational

Postoperative Pain Procedure Patient Remote Monitoring With MyHealthPal Clinical Study

The investigators want to explore the use of a smartphone app that allows patients to take photos of their wounds in early stages of healing, so that clinician…

Wound Infection and Wound Healing

Brigham and Women's HospitalNCT07391735

Phase 2

A Phase 2, Open-Label, Single-Arm, Sequential-Panel Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Posaconazole (POS, MK-5592) Intravenous and Powder for Oral Suspension Formulations in Pediatric Participants From Birth to Less Than 2 Years of Age With Possible, Probable, or Proven Invasive Fungal Infection

This study aims to estimate the pharmacokinetics (PK) of posaconazole (POS, MK-5592) intravenous (IV) and powder for oral suspension (PFS) formulations in pedi…

Invasive Fungal Infection

Merck Sharp & Dohme LLCNCT04665037

Phase 2

A Phase 2 Interventional, Open-Label, Single-Arm Trial of Oral Ibezapolstat (ACX-362E) for Treatment and Reduction of Recurrent Clostridioides Difficile Infection in Patients With Multiple Recurrent Infections (IBZ-PATHFINDER)

Single-arm trial to evaluate the safety and efficacy of ACX-362E \[ibezapolstat\] in patients with recurrent C. difficile infection (CDI).

Clostridium Difficile Infection Recurrence